While overall FY25 order flow stood at $3.4 billion, up 75 per cent year-on-year (Y-o-Y), about $2.1 billion came in Q4 alone
Virtual Galaxy Infotech aims to raise ₹93.29 crore through a fresh issue of ₹6.57 million equity shares
Mahanagar's stock was quoting at ₹1,404.90, up 2.03 per cent on the NSE after the company announced March 2025 quarter results
The subscription was led by non-institutional investors (NIIs), who bid for over 200 times the reserved quota, followed by retail investors at 92.23 times
Arunaya Organics shares listed at ₹30.10 per share on the NSE, reflecting a discount of ₹28.90 or 48 per cent against the issue price of ₹58 per share
The Nifty has near-support at 24,200, below which the key support will be the 200-DMA at 24,050 levels, shows the technical chart.
BEL, BDL, Mazagon Dock, HAL, Solar Inds, Astra Micro and Data Patterns seem favourably placed on the charts, and may gain up to 38%; here are key support, resistance levels for these 7 defence stocks.
Iware Supplychain shares listed at ₹85.05 per share on the NSE, reflecting a discount of ₹9.95 per share or 10 per cent against the issue price of ₹95 per share
DMart's stock slips after weak Q4 margin performance and cautious outlook as analysts flag rising cost pressures and competitive intensity in the FMCG segment
Marico share price today: Marico's stock was quoting at ₹721.70, up 3.43 per cent on the National Stock Exchange
India's defence sector ends FY25 with record orders as exports, reforms, and robust pipelines fuel bullish outlook for FY26 and beyond, driving strong gains in top defence stocks
Weekly market outlook, May 5 - 9, 2025: Sensex and Nifty seem favourably placed on charts; however, key momentum oscillators are showing signs of tiring out, hence an interim dip cannot be ruled out.
Kalyan Jewellers stock has swung over 40% twice so far in 2025, and over 30% four times in the last four months. Technical chart suggests that the stock could potentially rally over 25% from here on.
The alternative scenario, however, is grimmer. The mere threat of tariffs has led to near-recessive conditions in the US and pulled down global growth
Middleweight stocks are in demand, leading the market with better returns in April's recovery
Analysts believe that pharma shares continue to see buying interest, given the inelastic demand for medicines; tariffs, if any could have minimal impact on the industry.
A total of 11 pharma and healthcare-related stocks have rallied more than 20% thus far in April on hopes of a likely softer tariff-related stance by the US President Donald Trump.
The stock reacted badly, falling 5.2 per cent to close at ₹621.85 on Monday on the BSE
In the week ahead, Sensex is likely to swing between 78,200 to 80,230 range. Nifty may test 23,400 on the downside, and can potentially rally to 24,800 on the upside; suggests technical charts.
Darkest hour is over, MFI stocks soar 15-21% as crisis turns into catalyst